Dihydrofolate reductase (DHFR) is an essential enzyme that catalyzes the reduction of dihydrofolate to tetrahydrofolate, a critical step in the synthesis of nucleotides required for DNA replication and cell division. It is a target for several chemotherapeutic agents, such as methotrexate, due to its role in rapidly dividing cancer cells.